Proteros: Proteros Enters Into Oncology Collaboration and License Agreement With AstraZeneca
Proteros biostructures GmbH announced that it has signed an agreement with AstraZeneca to jointly discover and develop novel small molecules for the potential treatment of various types of cancer.
Read full article »
Proteros is a Germany-based CRO that provides services such as drug discovery and biophysical testing for sectors including biotechnology and pharmaceuticals.
Read more